(456.3) = -1.97. Distinct patterns of EC use were observed among reducers and nonreducers. These findings suggest that switching trials should consider incorporating increases in the daily number of EC puffs as a therapeutic target. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
No takes yet. Share an insight, caveat, or question.
Pericot‐Valverde et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: